Technology Decisions. Clearly Explained.
Lilly's March agreement with Insilico Medicine—$115M upfront for 28 AI-designed drug candidates—marks the first billion-dollar-plus validation of end-to-end generative AI in drug discovery.
Mid-market SaaS providers using Intel Trust Domain Extensions gain cryptographic memory isolation that hypervisors can't access, undercutting AWS and Azure in enterprise RFPs requiring confidential computing.
Zscaler's cloud proxy now handles over half a trillion daily transactions, forcing buyers to choose between cloud-native scale and legacy vendors retrofitting hardware.
Lark eliminated upfront licensing costs with a free tier supporting 20 users and 1,000 automation runs. This shifts enterprise pilots from paid plans to zero-risk testing.
Snowflake and OpenAI's $200 million deal embeds autonomous AI agents directly into existing data infrastructure, eliminating custom engineering barriers for enterprise deployment.
Supermicro's SuperEdge 3-node server shrinks footprints for factory IoT deployments by half. The move targets $23.5B in new edge spending by 2030.
Greenway Health's Novare platform integrates clinical and revenue cycle management into a single AI-native EHR, challenging Epic's modular approach and raising baseline feature expectations across ambulatory care.
AWS CEO forecasts revenue doubling to $600B by 2036 on enterprise AI workloads. Cloud buyers face multi-year capacity deals as hyperscalers prioritize GPU access over cost flexibility.
CVE-2025-12825 allows attackers to maintain access to FortiGate firewalls even after patches are applied, creating surge demand for alternative architectures and behavioral detection tools.
Adobe embeds Model Context Protocol into Marketo, enabling natural language campaign execution. Marketing ops teams face 20-30% time savings but higher vendor lock-in risk.
Claude reached 44% production usage in Q1 2026, up from 35% in May 2025, as enterprises abandon single-vendor strategies. OpenAI's 56% wallet share now faces pressure from buyers deploying three or more models.
Weekly analysis of the tools, platforms, and strategies that matter to B2B technology buyers. No fluff, no vendor spin.